Bioactive components of ovine and caprine cheese whey

Small Ruminant Research

Volumn 101, Issue 1-3, 2011, Pages 196-204

  Hernández Ledesma, Blanca ^a   Ramos, Mercedes ^a   Gómez Ruiz, José Ángel ^a  

^a INSTITUTE OF FOOD SCIENCE RESEARCH CIAL   (Spain)

Author keywords

Bioactive peptides; Bioactivity; Cheese whey; Health; Sheep and goat whey proteins

Indexed keywords

CAPRA; CAPRA HIRCUS; OVIS; OVIS ARIES;

EID: 81255135841     PISSN: 09214488     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.smallrumres.2011.09.040     Document Type: Review

References (90)

1. Abd El-Salam M.H., ElShibiny S., Buchheim W. Characteristics and potential uses of the casein macropeptide. Int. Dairy J. 1996, 6:327-341.
2. Antila P., Paakari I., Järvinen A., Mattila M.J., Laukkanen M., Pihlanto-Leppälä A., Mäntsälä P., Hellman J. Opioid peptides derived from in-vitro proteolysis of bovine whey proteins. Int. Dairy J. 1991, 1:215-229.
3. Azuma N., Yamauchi K., Mitsuoka T. Bifidus growth promoting activity of a glycomacropeptide derived from human k-casein. Agric. Biol. Chem. 1984, 48:2159-2162.
4. Balan P., Han K.S., Rutherfurd K., Singh H., Moughan P.J. Orally administered ovine serum immunoglobulins influence growth performance, organ weights, and gut morphology in growing rats. J. Nutr. 2009, 139:244-249.
5. Balan P., Han K.S., Rutherfurd-Markwick K., Singh H., Moughan P.J. Immunomodulatory effects of ovine serum immunoglobulin in the growing rat. Animal 2010, 4:1702-1710.
6. Bellamy W., Takase M., Wakabayashi H., Kawase K., Tomita M. Antibacterial spectrum of lactoferricin B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin. J. Appl. Bacteriol. 1992, 73:472-479.
7. Biziulevicius G.A., Kislukhina O.V., Kazlauskaite J., Zukaite V. Food-protein enzymatic hydrolysates possess both antimicrobial and immunostimulatory activities: a cause and effect theory of bifunctionality. FEMS Immunol. Med. Microbiol. 2006, 46:131-138.
8. Bordenave, S., 2000. Hydrolyse de lálpha-lactalbumine caprine en reacteur à ultrafiltration: génération et caractérisation de peptides issus de lóhydrolyse pepsique. Thèse, Université de la Rochelle, 155 pp.
9. Campagna S., Mathot A.-G., Fleury Y., Girardet J.-M., Gaillard J.-L. Antibacterial activity of lactophoricin, a synthetic 23-residues peptide derived from the sequence of Bovine Milk Component-3 of proteose peptone. J. Dairy Sci. 2004, 87:1621-1626.
10. Chatterton D.E.W., Smithers G., Roupas P., Brodkorb A. Bioactivity of β-lactoglobulin and α-lactalbumin-technological implications for processing. Int. Dairy J. 2006, 16:1229-1240.
11. Chobert J.M., El-Zahar K., Sitohy M., Dalgalarrondo M., Metro F., Choiset Y., Haertle T. Angiotensin I-converting-enzyme (ACE)-inhibitory activity of tryptic peptides of ovine beta-lactoglobulin and of milk yoghurts obtained by using different starters. Lait 2005, 85:141-152.
12. Choi J.K., Ho J., Curry S., Qin D.H., Bittman R., Hamilton J.A. Interactions of very long-chain saturated fatty acids with serum albumin. J. Lipid Res. 2002, 43:1000-1010.
13. Correia, R.T.P., Cruz, V.M.F., 2006. Leite de cabra e derivados. ACOSC-Associacão dos Criadores de Ovinos e Caprinos do Sertão do Cabugi. Bulletin.
14. de Wit J.N., van Hooydonk A.C.M. Structure, functions and applications of lactoperoxidase in natural antimicrobial systems. Neth. Milk Dairy J. 1996, 50:227-244.
15. Didelot S., Bordenave-Jurechereau S., Rosenfeld E., Fruitier-Arnaudin I., Piot J.M., Sannier F. Preparation of angiotensin-I-converting enzyme inhibitory hydrolysates from unsupplemented caprine whey fermentation by various cheese microflora. Int. Dairy J. 2006, 16:976-983.
16. El-Zahar K., Sitohy M., Choiset Y., Metro F., Haertle T., Chobert J.M. Antimicrobial activity of ovine whey protein and their peptic hydrolysates. Milchwissenschaft 2004, 59:653-656.
17. European Food Safety Authority EFSA J. 2010, 8(10):1818. (28 pp.). 10.2903/j.efsa.2010.1818.
18. Fox P.F., Guinee T.P., Cogan T.M., McSweeney P.L.H. Chemistry of milk constituents. Fundamentals of Cheese Science 2000, Aspen Publishers, Gaithersburg, MD, pp. 19-44.
19. Ganjam L.S., Thornton W.H., Marshall R.T., MacDonald R.S. Antiproliferative effects of yoghurt fractions obtained by membrane dialysis on cultured mammalian intestinal cells. J. Dairy Sci. 1997, 80:2325-2339.
20. Hallgren O., Aits S., Brest P., Gustafsson L., Mossberg A.K., Wullt B., Svanborg C. Apoptosis and tumor cell death in response to HAMLET (human alpha-lactalbumin made lethal to tumor cells). Adv. Exp. Med. Biol. 2008, 606:217-240.
21. Hahn R., Schulz P.M., Schaupp C., Jungbauer A. Bovine whey fractionation based on cation-exchange chromatography. J. Chromatogr. A 1998, 795:277-287.
22. Hamme V., Sannier F., Piot J.M., Didelot S., Bordenave-Juchereau S. Crude goat whey fermentation by Kluyveromyces marxianus and Lactobacillus rhamnosus: contribution to proteolysis and ACE inhibitory activity. J. Dairy Res. 2009, 76:152-157.
23. Hernández-Ledesma B., Dávalos A., Bartolomé B., Amigo L. Preparation of antioxidant enzymatic hydrolyzates from α-lactalbumin and β-lactoglobulin. Identification of peptides by HPLC-MS/MS. J. Agric. Food Chem. 2005, 53:588-593.
24. Hernández-Ledesma B., Miguel M., Amigo L., Aleixandre M.A., Recio I. Effect of simulated gastrointestinal digestion on the antihypertensive properties of β-lactoglobulin peptides. J. Dairy Res. 2007, 74:336-339.
25. Hernández-Ledesma B., Recio I., Amigo L. β-Lactoglobulin as source of bioactive peptides. Amino Acids 2008, 35:257-265.
26. Hernández-Ledesma B., Recio I., Ramos M., Amigo L. Preparation of ovine and caprine β-Lg hydrolysates with ACE-inhibitory activity. Identification of active peptides from β-Lg hydrolysed with thermolysin. Int. Dairy J. 2002, 12:805-812.
27. Hou I.C., Yoshikawa M., Ohinata K. beta-Lactotensin derived from bovine beta-lactoglobulin suppresses food intake via the CRF system followed by the CGRP system in mice. Peptides 2009, 30:2228-2232.
28. Idota T., Kawakami H., Nakajima I. Bifidobacterium growth promoting activity effect of N-acetylneuraminic acid containing substances. Biosci. Biotechnol. Biochem. 1994, 58:1720-1722.
29. Jacquot A., Gauthier S.F., Drouin R., Boutin Y. Proliferative effects of synthetic peptides from beta-lactoglobulin and alpha-lactalbumin on murine splenocytes. Int. Dairy J. 2010, 20:514-521.
30. Kawasaki Y., Isoda H., Shinmoto H., Tanimoto M., Dosako S., Idota T., Nakajima I. Inhibition by k-casein glycomacropeptide and lactoferrin of influenza virus hemmaglutination. Biosci. Biotechnol. Biochem. 1993, 57:1214-1215.
31. Kawasaki Y., Isoda H., Tanimoto M., Dosako S., Idota T., Ahiko K. Inhibition by lactoferrin and k-casein glycomacropeptide of binding of Cholera toxin to its receptor. Biosci. Biotechnol. Biochem. 1992, 56:195-198.
32. Kushibiki S., Hodate K., Kurisaki J., Shingu H., Ueda Y., Watanabe A., Shinoda M. Effect of beta-lactoglobulin on plasma retinol and triglyceride concentrations, and fatty acid composition in calves. J. Dairy Res. 2001, 68:579-586.
33. Laursen I., Briand P., Lykkesfeldt A.E. Serum-albumin as a modulator on growth of the human breast cancer cell line, MCF-7. Anticancer Res. 1990, 10:343-351.
34. Lister I.M., Rasmussen L.K., Johnsen L.B., Møller L., Petersen T.E., Sørensen E.S. The primary structure of caprine PP3: amino acid sequence, phosphorylation, and glycosylation of component PP3 from the proteose-peptone fraction of caprine milk. J. Dairy Sci. 1998, 81:2111-2115.
35. Luhovyy B.L., Akhavan T., Anderson G.H. Whey proteins in the regulation of food intake and satiety. J. Am. Coll. Nutr. 2007, 26:704S-712S.
36. Madureira A.R., Tavares T., Gomes A.M.P., Pintado M.E., Malcata F.X. Invited review: physiological properties of bioactive peptides obtained from whey proteins. J. Dairy Sci. 2010, 93:437-455.
37. Manso M.A., Escudero C., Alijo M., López-Fandiño R. Platelet aggregation inhibitory activity of bovine, ovine, and caprine kappa-casein macropeptides and their tryptic hydrolysates. J. Food Prot. 2002, 65:1992-1996.
38. Manso M.A., López-Fandiño R. Angiotensin I converting enzyme-inhibitory activity of bovine, ovine, and caprine kappa-casein macropeptides and their tryptic hydrolysates. J. Food Prot. 2003, 66:1686-1692.
39. Manso M.A., López-Fandiño R. Kappa-casein macropeptides from cheese whey: physicochemical, biological, nutritional, and technological features for possible uses. Food Rev. Int. 2004, 20:329-355.
40. Markus C.R., Olivier B., de Haan E.H. Whey protein rich in α-lactalbumin increases the ratio of plasma tryptophan to the sum of the other large neutral amino acids and improves cognitive performance in stress-vulnerable subjects. Am. J. Clin. Nutr. 2002, 75:1051-1056.
41. Mcintosh G.H., Regester G.D., Lelue R.K., Royle P.J., Smithers G.W. Dairy proteins protect against dimethylhydrazine-induced intestinal cancers in rats. J. Nutr. 1995, 125:809-816.
42. Mercier A., Gauthier S.F., Fliss L. Immunomodulating effects of whey proteins and their enzymatic digests. Int. Dairy J. 2004, 14:175-183.
43. Mikkelsen T.L., Rasmussen E., Olsen A., Barkholt V., Frokiaer H. Immunogenicity of kappa-casein and glycomacropeptide. J. Dairy Sci. 2006, 89:824-830.
44. Morris P.E., Fitzgerald R.J. Whey proteins and peptides in human health. Whey Processing, Functionality and Health Benefits 2008, 285-384. Wiley-Blackwell, IA, USA. C.I. Onwulata, P.J. Huth (Eds.).
45. Mullally M.M., Meisel H., FitzGerald R.J. Synthetic peptides corresponding to alpha-lactalbumin and beta-lactoglobulin sequences with angiotensin-I-converting enzyme inhibitory activity. Biol. Chem. Hoppe-Seyler 1996, 377:259-260.
46. Nagaoka S., Futamura Y., Miwa K., Awano T., Yamauchi K., Kanamaru Y., Tadashi K., Kuwata T. Identification of novel hypocholesterolaemic peptides derived from bovine milk β-lactoglobulin. Biochem. Biophys. Res. Commun. 2001, 281:11-17.
47. Nagaoka S., Kanamaru Y., Kuzuya Y. Effects of whey-protein and casein on the plasma and liver lipids in rats. Agric. Biol. Chem. 1991, 55:813-818.
48. Nagaoka S., Kanamaru Y., Kuzuya Y., Kojima T., Kuwata T. Comparative-studies on the serum-cholesterol lowering action of whey-protein and soybean-protein in rats. Biosci. Biotechnol. Biochem. 1992, 56:1484-1485.
49. Nurminen M.-L., Sipola M., Kaarto H., Pihlanto-Leppälä A., Piilola K., Korpela R., Tossavainen O., Vapaatalo H. α-Lactorphin lowers blood pressure measured by radiotelemetry in normotensive and spontaneously hypertensive rats. Life Sci. 2000, 66:1535-1543.
50. Oh S., Worobo R.W., Kim B., Rheem S., Kim S. Detection of cholera toxin-binding activity of k-casein macropeptide and optimization of its production by the response surface methodology. Biosci. Biotechnol. Biochem. 2000, 64:516-522.
51. Ohinata K., Sonoda A., Inoue N., Yamauchi R., Wada K., Yoshikawa M. Beta-lactotensin, a neurotensin agonist peptide derived from bovine beta-lactoglobulin, enhances memory consolidation in mice. Peptides 2007, 28:1470-1474.
52. Olakanimi O., Rasmussen G.T., Lewis T.S., Stokes J.B., Kemp J.D., Britigan B.E. Multivalent metal-induced iron acquisition from transferrin and lactoferrin by myeloid cells. J. Immunol. 2002, 169:2076-2084.
53. Orsi N. The antimicrobial activity of lactoferrin: current status and perspectives. Biometals 2004, 17:189-196.
54. Otani H., Horimoto Y., Monnai M. Suppression of interleukin-2 receptor expression on mouse CD4+ T cells by bovine k-caseinoglycopeptide. Biosci. Biotechnol. Biochem. 1996, 60:1017-1019.
55. Otani H., Monnai M. Induction of an interleukin-1 receptor antagonist-like component produced from mouse spleen cells by bovine k-caseinoglycopeptide. Biosci. Biotechnol. Biochem. 1995, 59:1166-1168.
56. Otani H., Monnai M., Kawasaki Y., Kawakami H., Tanimoto M. Inhibition of mitogen-induced proliferative responses of lymphocytes by bovine k-caseinoglycopeptides having different carbohydrate chains. J. Dairy Res. 1995, 62:349-357.
57. Pandya A.J., Ghodke K.M. Goat and sheep milk products other than cheeses and yoghurt. Small Rumin. Res. 2007, 68:193-206.
58. Park Y.W. Bioactive components in goat milk. Bioactive Components in Milk and Dairy Products 2009, 43-81. Wiley-Blackwell/John Wiley & Sons, Ltd. Publication. Y.W. Park (Ed.).
59. Park Y.W., Juárez M., Ramos M., Haenlein G.F.W. Physico-chemical characteristics of goat and sheep milk. Small Rumin. Res. 2007, 68:88-113.
60. Pellegrini A., Dettling C., Thomas U., Hunziker P. Isolation and characterization of four bactericidal domains in the bovine β-lactoglobulin. Biochim. Biophys. Acta 2001, 1526:131-140.
61. Pérez M.D., Sánchez L., Aranda P., Ena J.M., Oria R., Calvo M. Effect of beta-lactoglobulin on the activity of pregastric lipase a possible role for this protein in ruminant milk. Biochim. Biophys. Acta 1992, 1123:151-155.
62. Phillips S.M., Tang J.E., Moore D.R. The role of milk- and soy-based protein in support of muscle protein synthesis and muscle protein accretion in young and elderly persons. J. Am. Coll. Nutr. 2009, 28:343-354.
63. Pihlanto-Leppälä A. Bioactive peptides derived from bovine whey proteins: opioid and ace-inhibitory peptides. Trends Food Sci. Technol. 2001, 11:347-356.
64. Prioult G., Pecquet S., Fliss I. Stimulation of interleukin-10 production by acidic beta-lactoglobulin-derived peptides hydrolyzed with Lactobacillus paracasei NCC2461 peptidases. Clin. Diagn. Lab. Immunol. 2004, 11:266-271.
65. Recio I., De la Fuente M.A., Juárez M., Ramos M. Bioactive components in sheep milk. Bioactive Components in Milk and Dairy Products. 2009, 83-104. Wiley-Blackwell/John Wiley & Sons, Ltd. Publication. Y.W. Park (Ed.).
66. Qian Z.Y., Jollès P., Migliore-Samour D., Fiat A.M. Isolation and characterization of sheep lactoferrin, an inhibitor of platelet-aggregation and comparison with human lactoferrin. Biochim. Biophys. Acta 1995, 1243:25-32.
67. Qian Z.Y., Jollès P., Migliore-Samour D., Schoentgen F., Fiat A.M. Sheep kappa-casein peptides inhibit platelet-aggregation. Biochim. Biophys. Acta 1995, 1244:411-417.
68. Rammer P., Groth-Pedersen L., Kirkegaard T., Daugaard M., Rytter A., Szyniarowski P., Høyer-Hansen M., Povlsen L.K., Nylandsted J., Larsen J.E., Jäättelä M. BAMLET activates a lysosomal cell death program in cancer cells. Mol. Cancer Ther. 2010, 9:24-32.
69. Raynal-Ljutovaca K., Lagriffoul G., Paccard P., Guillet I., Chilliard Y. Composition of goat and sheep milk products: an update. Small Rumin. Res. 2008, 79:57-72.
70. Recio I., Visser S. Antibacterial and binding characteristics of bovine, ovine and caprine lactoferrins: a comparative study. Int. Dairy J. 2000, 10:597-605.
71. Setarehnejad A., Kanekanian A., Tatham A., Abedi A.H. The protective effect of caseinomacropeptide against dental erosion using hydroxyapatite as a model system. Int. Dairy J. 2010, 20:652-656.
72. Shin K., Wakabayashi H., Yamauchi K., Teraguchi S., Tamura Y., Kurokawa M., Shiraki K. Effects of orally administered bovine lactoferrin and lactoperoxidase on influenza virus infection in mice. J. Med. Microbiol. 2005, 54:717-723.
73. Sipola M., Finckenberg P., Vapaatalo H., Pihlanto-Leppälä A., Korhonen H., Korpela R., Nurminen M.-L. α-Lactorphin and β-lactorphin improve arterial function in spontaneously hypertensive rats. Life Sci. 2002, 71:1245-1253.
74. Smith C., Halliwell B., Aruoma O.I. Protection by albumin against the prooxidant actions of phenolic dietary-components. Food Chem. Toxicol. 1992, 30:483-489.
75. Sreedhara A., Flengsrud R., Langsrud T., Kaul P., Prakash V., Vegarud G.E. Structural characteristic, pH and thermal stabilities of apo and holo forms of caprine and bovine lactoferrins. Biometals 2010, 23:1159-1170.
76. Storry J.E., Grandison A.S., Millard D., Owen A.J., Ford G.D. Chemical composition and coagulating properties of renneted milks from different breeds and species of ruminants. J. Dairy Res. 1983, 50:215-229.
77. Sugahara T., Onda H., Shinohara Y., Horii M., Akiyama K., Nakamoto K., Hara K. Immunostimulation effects of proteose-peptone component 3 fragment on human hybridomas and peripheral blood lymphocytes. Biochim. Biophys. Acta 2005, 1725:233-240.
78. Sutton L.F., Alston-Mills B. Beta-lactoglobulin as a potential modulator of intestinal activity and morphology in neonatal piglets. Anat. Rec. A Discov. Mol. Cell. Evol. Biol. 2006, 288:601-608.
79. Thoma-Worringer C., Sorensen J., López-Fandiño R. Health effects and technological features of caseinomacropeptide. Int. Dairy J. 2006, 16:1324-1333.
80. Togawa J., Nagase H., Tanaka K., Inamori M., Umezawa T., Nakajima A., Naito M., Sato S., Saito T., Sekihara H. Lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance. Am. J. Physiol. Gastrointest. Liver Physiol. 2002, 283:187-195.
81. Van der Strate B.W., Beljaars L., Molema G., Harmsen M.C., Meijer D.K. Antiviral activities of lactoferrin. Antiviral Res. 2001, 52:225-239.
82. Wakabayashi H., Miyauchi H., Shin K., Yamauchi K., Matsumoto I., Abe K., Takase M. Orally administered lactoperoxidase increases expression of the FK506 binding protein 5 gene in epithelial cells of the small intestine of mice: a DNA microarray study. Biosci. Biotechnol. Biochem. 2007, 71:2274-2282.
83. Wakabayashi H., Takase M., Tomita M. Lactoferricin derived from milk protein lactoferrin. Curr. Pharm. Des. 2003, 9:1277-1287.
84. Wong K.F., Middleton N., Montgomery M., Dey M., Carr R.I. Immunostimulation of murine spleen cells by materials associated with bovine milk protein fractions. J. Dairy Sci. 1998, 81:1825-1832.
85. Xu X.X., Jiang H.R., Li H.B., Zhang T.N., Zhou Q., Liu N. Apoptosis of stomach cancer cell SGC-7901 and regulation of Akt signaling way induced by bovine lactoferrin. J. Dairy Sci. 2010, 93:2344-2350.
86. Yalcin A.S. Emerging therapeutic potential of whey proteins and peptides. Curr. Pharm. Des. 2006, 12:1637-1643.
87. 2 receptor. Peptides 2003, 24:1955-1961.
88. Yamauchi R., Usui H., Yunden J., Takenaka Y., Tani F., Yoshikawa M. Characterization of β-lactotensin, a bioactive peptide derived from bovine β-lactoglobulin, as a neurotensin agonist. Biosci. Biotechnol. Biochem. 2003, 67:940-943.
89. Yamauchi R., Wada E., Yamada D., Yoshikawa M., Wada K. Effect of β-lactotensin on acute stress and fear memory. Peptides 2006, 27:3176-3182.
90. Yoshikawa, M., Sasaki, R., Chiba, H., Tani, F., 1991. Japan Kokai Tokkyo Koho, 220197 (Sep. 27).